MSLE

Satellos Bioscience Inc. Common Stock

NASDAQ: MSLE · HEALTHCARE · BIOTECHNOLOGY

$7.26

-6.49% today

Updated 2026-06-05

Market cap

$118.95M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.78

Dividend yield

—

52W range

$5 – $13

Volume

0.0M

Market cap

$118.95M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.78

Dividend yield

—

52W range

$5 – $13

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.3

Quality

C+

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-1.2

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →199 stocks currently score above 75

Price targets

Analyst target

$27.67

+281.13%

12-Month target

$6.19

-14.74%

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -1.23 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-9.46M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-11.21M	$-11.98M	$-19.58M	$-24.87M	$-9.77M
EPS	—	—	—	—	$-1.78
Free cash flow	$-5.73M	$-14.44M	$-17.41M	$-23.60M	$-9.46M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MSLE	$118.95M	28	4.3	3.0	5.0	5.3	—	Avoid
LLY	$1.01T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$567.28B	57	4.7	9.0	3.3	6.0	-67.79%	Buy
ABBV	$391.50B	63	4.0	8.0	4.0	5.0	-48.06%	Buy
UNH	$373.28B	54	5.3	5.5	4.0	5.5	-24.80%	Buy
NVS	$289.19B	49	3.3	9.0	3.3	4.5	-65.15%	Hold

Smart narrative

Satellos Bioscience Inc. Common Stock trades at $7.26. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -1.23, it sits in the distress.

Frequently asked questions

What is Satellos Bioscience Inc. Common Stock's stock price?

Satellos Bioscience Inc. Common Stock (MSLE) trades at $7.26.

Is Satellos Bioscience Inc. Common Stock overvalued?

Satellos Bioscience Inc. Common Stock carries a Smart Value Score of 28/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Satellos Bioscience Inc. Common Stock (MSLE)?

The 12-month analyst consensus target is $27.67, about 281.1% above the current $7.26. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Satellos Bioscience Inc. Common Stock's Altman Z-Score is -1.23, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-40.01%

Beta1.17

50D MA$7.00

200D MA$7.37

Shares out0.02B

Float0.02B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

MSLE vs LLY →MSLE vs JNJ →MSLE vs ABBV →Stock screener →